Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.390
-0.090 (-6.08%)
Feb 19, 2026, 12:22 PM EST - Market open

Celularity Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
404747187632395
Market Cap Growth
-11.74%-1.00%-74.75%-70.41%59.91%10.55%
Enterprise Value
109116106212590-
Last Close Price
1.482.082.4712.9051.20110.00
PE Ratio
---13.18--
PS Ratio
1.050.862.0810.4129.6327.69
PB Ratio
-5.291.150.946.3621.13
P/TBV Ratio
--2.09---
EV/Sales Ratio
2.692.134.6611.7727.68-
Debt / Equity Ratio
-3.327.791.600.330.311.64
Net Debt / Equity Ratio
-3.327.711.590.26-0.06-1.26
Net Debt / EBITDA Ratio
-1.61-2.22-0.97-0.370.050.34
Net Debt / FCF Ratio
-10.02-10.38-1.64-0.360.050.26
Asset Turnover
0.330.390.080.040.050.03
Inventory Turnover
6.142.692.902.651.441.39
Quick Ratio
0.100.270.150.301.532.08
Current Ratio
0.160.380.290.542.252.71
Return on Equity (ROE)
--232.51%-163.67%9.52%-169.50%-265.99%
Return on Assets (ROA)
-25.03%-17.42%-17.54%-22.73%-20.36%-10.25%
Return on Invested Capital (ROIC)
-107.75%-42.11%-42.88%-86.16%-311.65%-117.57%
Return on Capital Employed (ROCE)
-99.50%-48.80%-99.90%-43.70%-35.50%-19.30%
Earnings Yield
-188.96%-123.79%-415.52%7.59%-15.84%-52.68%
FCF Yield
-15.58%-14.03%-84.11%-76.50%-18.40%-23.03%
Buyback Yield / Dilution
-13.94%-22.89%-18.89%-123.44%-264.09%22.85%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q